Small Molecules
Lysosomal storage disorders are rare genetic disorders due to deficient lysosomal activity, which leads to progressive accumulation of nonmetabolized substrates. Patient’s clinical outcomes have significantly improved since the advent of enzyme replacement therapy, even though this therapeutic appro...
Main Author: | Saida Ortolano PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
SciELO
2016-08-01
|
Series: | Journal of Inborn Errors of Metabolism and Screening |
Online Access: | https://doi.org/10.1177/2326409816666297 |
Similar Items
-
Radiosensitizing activity of novel small molecule BRCA1 and DNA-PK inhibitors in lung and colon carcinoma
by: Suraj Radhamani, Ph.D, et al.
Published: (2017-07-01) -
Diarrhea Induced by Small Molecule Tyrosine Kinase Inhibitors Compared With Chemotherapy: Potential Role of the Microbiome
by: Kate R. Secombe BHSc (Hons), et al.
Published: (2020-06-01) -
New Insights in the Amyloid-Beta Interaction with Mitochondria
by: Carlos Spuch, et al.
Published: (2012-01-01) -
Discovery of Novel Small Molecules that Block Myofibroblast Formation: Implications for Capsular Contracture Treatment
by: Rachel H. Park, BA, et al.
Published: (2019-09-01) -
Materials design and discovery of catalysts for small molecule conversion
by: Hwang, Jonathan,Ph.D.Massachusetts Institute of Technology.
Published: (2019)